Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KRE vs GSK✓SelectedUSD · GSKKRE vs GSK performance historyLatest closeAs of+0.30%11/13
Stock and ETF performance explorer

KRE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+83.8%
GSK return
+105.0%
Excess return
-21.1%
Maximum drawdown
-55.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%+0.5%-0.2%+0.1%
7D+0.7%+1.1%-0.4%+0.4%
30D+6.1%+6.3%-0.2%+4.1%
3M-5.9%+1.8%-7.7%-6.7%
6M+9.6%+1.7%+7.9%+8.4%
YTD+14.2%+6.5%+7.6%+10.9%
1Y+22.5%+9.5%+13.0%+17.8%
3Y+90.4%+65.3%+25.1%+52.0%
5Y+11.9%+43.7%-31.9%-6.8%
All+83.8%+105.0%-21.1%+35.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling